Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument “Pro”

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S10-S15
JournalClinical Lymphoma, Myeloma and Leukemia
Volume17
DOIs
StatePublished - Jul 2017

Keywords

  • ALL
  • Hematopoetic cell transplantation
  • Minimal residual disease
  • Philadelphia chromosome
  • Tyrosine kinase inhibitors

Cite this